無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の癌幹細胞市場規模、動向、予測(2018〜2025年)

Global Cancer Stem Cell Market Size, Status and Forecast 2018-2025

発行 QYResearch 商品コード 680017
出版日 ページ情報 英文 95 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=114.42円で換算しております。
Back to Top
世界の癌幹細胞市場規模、動向、予測(2018〜2025年) Global Cancer Stem Cell Market Size, Status and Forecast 2018-2025
出版日: 2018年08月20日 ページ情報: 英文 95 Pages
概要

癌幹細胞は別の集団として腫瘍の中で増殖し、新たな腫瘍の生成を通じて既存の腫瘍の劣化と転移を引き起こします。癌細胞研究分野の技術進歩により、癌幹細胞を標的とした治療がクオリティオブライフを向上させ、転移疾患を患う癌患者の生存率を上げると期待されています。

当レポートでは、世界の癌幹細胞市場について調査し、市場の現状と2025年までの成長予測、タイプ別、用途別、地域別動向、および市場に参入する企業のプロファイルなどをまとめています。

第1章 レポートの概要

第2章 世界の成長動向

  • 市場規模
  • 地域別成長動向
  • 業界動向

第3章 主要企業による市場シェア

  • 製造業者別市場規模
  • 主要企業の本社と事業範囲
  • 製品/ソリューション/サービス
  • 市場参入日
  • 合併・買収、拡充計画

第4章 タイプと用途別内訳データ

第5章 米国

第6章 欧州

第7章 中国

第8章 日本

第9章 東南アジア

第10章 インド

第11章 中南米

第12章 国際的企業プロファイル

  • Thermo Fisher Scientific, Inc.
  • AbbVie, Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics, Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics, Inc.
  • OncoMed Pharmaceuticals, Inc.
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • Sino Biological Inc.
  • BIOTIME, Inc.

第13章 市場予測

第14章 アナリストの見解/結論

第15章 付録

図表

List of Tables and Figures

  • Table Cancer Stem Cell Key Market Segments
  • Table Key Players Cancer Stem Cell Covered
  • Table Global Cancer Stem Cell Market Size Growth Rate by Type 2013-2025 (Million US$)
  • Figure Global Cancer Stem Cell Market Size Market Share by Type 2013-2025
  • Figure Cell Culturing Figures
  • Table Key Players of Cell Culturing
  • Figure Cell Separation Figures
  • Table Key Players of Cell Separation
  • Figure Cell Analysis Figures
  • Table Key Players of Cell Analysis
  • Figure Molecular Analysis Figures
  • Table Key Players of Molecular Analysis
  • Figure Others Figures
  • Table Key Players of Others
  • Table Global Cancer Stem Cell Market Size Growth by Application 2013-2025 (Million US$)
  • Figure Stem Cell Based Cancer Therapy Case Studies
  • Figure Targeted CSCs Case Studies
  • Figure Cancer Stem Cell Report Years Considered
  • Table Global Cancer Stem Cell Market Size 2013-2025 (Million US$)
  • Figure Global Cancer Stem Cell Market Size and Growth Rate 2013-2025 (Million US$)
  • Table Global Cancer Stem Cell Market Size by Regions 2013-2025 (Million US$)
  • Table Global Cancer Stem Cell Market Size by Regions 2013-2018 (Million US$)
  • Table Global Cancer Stem Cell Market Share by Regions 2013-2018
  • Figure Global Cancer Stem Cell Market Share by Regions 2013-2018
  • Figure Global Cancer Stem Cell Market Share by Regions 2018
  • Table Market Top Trends
  • Table Global Cancer Stem Cell Revenue by Manufacturers (2013-2018) (Million US$)
  • Table Global Cancer Stem Cell Market Share by Manufacturers (2013-2018)
  • Figure Global Cancer Stem Cell Market Share by Manufacturers in 2018
  • Table Global Cancer Stem Cell Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Cancer Stem Cell Product/Solution/Service
  • Table Date of Enter into Cancer Stem Cell Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table Global Cancer Stem Cell Market Size Share by Type (2013-2018)
  • Figure Global Cancer Stem Cell Market Size Market Share by Type (2013-2018)
  • Table Global Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table Global Cancer Stem Cell Market Size Share by Application (2013-2018)
  • Figure Global Cancer Stem Cell Market Size Market Share by Application (2013-2018)
  • Figure Global Cancer Stem Cell Revenue Market Share by Application in 2017
  • Figure United States Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table United States Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table United States Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table United States Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table United States Cancer Stem Cell Market Share by Type (2013-2018)
  • Table United States Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table United States Cancer Stem Cell Market Share by Application (2013-2018)
  • Figure Europe Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table Europe Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table Europe Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table Europe Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table Europe Cancer Stem Cell Market Share by Type (2013-2018)
  • Table Europe Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table Europe Cancer Stem Cell Market Share by Application (2013-2018)
  • Figure China Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table China Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table China Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table China Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table China Cancer Stem Cell Market Share by Type (2013-2018)
  • Table China Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table China Cancer Stem Cell Market Share by Application (2013-2018)
  • Figure Japan Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table Japan Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table Japan Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table Japan Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table Japan Cancer Stem Cell Market Share by Type (2013-2018)
  • Table Japan Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table Japan Cancer Stem Cell Market Share by Application (2013-2018)
  • Figure Southeast Asia Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table Southeast Asia Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table Southeast Asia Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table Southeast Asia Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table Southeast Asia Cancer Stem Cell Market Share by Type (2013-2018)
  • Table Southeast Asia Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table Southeast Asia Cancer Stem Cell Market Share by Application (2013-2018)
  • Figure India Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table India Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table India Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table India Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table India Cancer Stem Cell Market Share by Type (2013-2018)
  • Table India Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table India Cancer Stem Cell Market Share by Application (2013-2018)
  • Figure Central & South America Cancer Stem Cell Market Size 2013-2018 (Million US$)
  • Table Central & South America Key Players Cancer Stem Cell Revenue (2017-2018) (Million US$)
  • Table Central & South America Key Players Cancer Stem Cell Market Share (2017-2018)
  • Table Central & South America Cancer Stem Cell Market Size by Type (2013-2018) (Million US$)
  • Table Central & South America Cancer Stem Cell Market Share by Type (2013-2018)
  • Table Central & South America Cancer Stem Cell Market Size by Application (2013-2018) (Million US$)
  • Table Central & South America Cancer Stem Cell Market Share by Application (2013-2018)
  • Table Thermo Fisher Scientific, Inc. Company Details
  • Table Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2013-2018) (Million US$)
  • Figure Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table Thermo Fisher Scientific, Inc. Recent Development
  • Table AbbVie, Inc. Company Details
  • Table AbbVie, Inc. Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure AbbVie, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table AbbVie, Inc. Recent Development
  • Table Merck KGaA Company Details
  • Table Merck KGaA Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure Merck KGaA Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table Merck KGaA Recent Development
  • Table Bionomics Company Details
  • Table Bionomics Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure Bionomics Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table Bionomics Recent Development
  • Table Lonza Company Details
  • Table Lonza Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure Lonza Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table Lonza Recent Development
  • Table Stemline Therapeutics, Inc. Company Details
  • Table Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure Stemline Therapeutics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table Stemline Therapeutics, Inc. Recent Development
  • Table Miltenyi Biotec Company Details
  • Table Miltenyi Biotec Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure Miltenyi Biotec Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table Miltenyi Biotec Recent Development
  • Table PromoCell GmbH Company Details
  • Table PromoCell GmbH Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure PromoCell GmbH Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table PromoCell GmbH Recent Development
  • Table MacroGenics, Inc. Company Details
  • Table MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure MacroGenics, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table MacroGenics, Inc. Recent Development
  • Table OncoMed Pharmaceuticals, Inc. Company Details
  • Table OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2013-2018)(Million US$)
  • Figure OncoMed Pharmaceuticals, Inc. Revenue Growth Rate in Cancer Stem Cell Business (2013-2018)
  • Table OncoMed Pharmaceuticals, Inc. Recent Development
  • Table Irvine Scientific Company Details
  • Table STEMCELL Technologies Inc. Company Details
  • Table Sino Biological Inc. Company Details
  • Table BIOTIME, Inc. Company Details
  • Table Global Cancer Stem Cell Market Size by Regions (Million US$) 2018-2025
  • Figure Global Cancer Stem Cell Market Size Share by Regions (2018-2025)
  • Figure Global Cancer Stem Cell Market Size Share by Regions in 2025
  • Figure United States Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Figure Europe Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Figure China Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Figure Japan Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Figure Southeast Asia Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Figure India Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Figure Central & South America Cancer Stem Cell Market Size Forecast (2018-2025)(Million USD)
  • Table Global Cancer Stem Cell Market Size by Product (2018-2025) (Million US$)
  • Figure Global Cancer Stem Cell Market Size by Product (2018-2025)
  • Figure Global Cancer Stem Cell Market Size by Product in 2025
  • Table Global Cancer Stem Cell Market Size by Application (2018-2025) (Million US$)
  • Figure Global Cancer Stem Cell Market Size by Application (2018-2025)
  • Figure Global Cancer Stem Cell Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
目次

This report focuses on the global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Stem Cell development in United States, Europe and China.

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.

North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.

Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.

In 2017, the global Cancer Stem Cell market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

  • Thermo Fisher Scientific, Inc.
  • AbbVie, Inc.
  • Merck KGaA
  • Bionomics
  • Lonza
  • Stemline Therapeutics, Inc.
  • Miltenyi Biotec
  • PromoCell GmbH
  • MacroGenics, Inc.
  • OncoMed Pharmaceuticals, Inc.
  • Irvine Scientific
  • STEMCELL Technologies Inc.
  • Sino Biological Inc.
  • BIOTIME, Inc.

Market segment by Type, the product can be split into

  • Cell Culturing
  • Cell Separation
  • Cell Analysis
  • Molecular Analysis
  • Others

Market segment by Application, split into

  • Stem Cell Based Cancer Therapy
  • Targeted CSCs

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players.
  • To present the Cancer Stem Cell development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Stem Cell are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1. Report Overview

  • 1.1. Study Scope
  • 1.2. Key Market Segments
  • 1.3. Players Covered
  • 1.4. Market Analysis by Type
    • 1.4.1. Global Cancer Stem Cell Market Size Growth Rate by Type (2013-2025)
    • 1.4.2. Cell Culturing
    • 1.4.3. Cell Separation
    • 1.4.4. Cell Analysis
    • 1.4.5. Molecular Analysis
    • 1.4.6. Others
  • 1.5. Market by Application
    • 1.5.1. Global Cancer Stem Cell Market Share by Application (2013-2025)
    • 1.5.2. Stem Cell Based Cancer Therapy
    • 1.5.3. Targeted CSCs
  • 1.6. Study Objectives
  • 1.7. Years Considered

2. Global Growth Trends

  • 2.1. Cancer Stem Cell Market Size
  • 2.2. Cancer Stem Cell Growth Trends by Regions
    • 2.2.1. Cancer Stem Cell Market Size by Regions (2013-2025)
    • 2.2.2. Cancer Stem Cell Market Share by Regions (2013-2018)
  • 2.3. Industry Trends
    • 2.3.1. Market Top Trends
    • 2.3.2. Market Drivers
    • 2.3.3. Market Opportunities

3. Market Share by Key Players

  • 3.1. Cancer Stem Cell Market Size by Manufacturers
    • 3.1.1. Global Cancer Stem Cell Revenue by Manufacturers (2013-2018)
    • 3.1.2. Global Cancer Stem Cell Revenue Market Share by Manufacturers (2013-2018)
    • 3.1.3. Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
  • 3.2. Cancer Stem Cell Key Players Head office and Area Served
  • 3.3. Key Players Cancer Stem Cell Product/Solution/Service
  • 3.4. Date of Enter into Cancer Stem Cell Market
  • 3.5. Mergers & Acquisitions, Expansion Plans

4. Breakdown Data by Type and Application

  • 4.1. Global Cancer Stem Cell Market Size by Type (2013-2018)
  • 4.2. Global Cancer Stem Cell Market Size by Application (2013-2018)

5. United States

  • 5.1. United States Cancer Stem Cell Market Size (2013-2018)
  • 5.2. Cancer Stem Cell Key Players in United States
  • 5.3. United States Cancer Stem Cell Market Size by Type
  • 5.4. United States Cancer Stem Cell Market Size by Application

6. Europe

  • 6.1. Europe Cancer Stem Cell Market Size (2013-2018)
  • 6.2. Cancer Stem Cell Key Players in Europe
  • 6.3. Europe Cancer Stem Cell Market Size by Type
  • 6.4. Europe Cancer Stem Cell Market Size by Application

7. China

  • 7.1. China Cancer Stem Cell Market Size (2013-2018)
  • 7.2. Cancer Stem Cell Key Players in China
  • 7.3. China Cancer Stem Cell Market Size by Type
  • 7.4. China Cancer Stem Cell Market Size by Application

8. Japan

  • 8.1. Japan Cancer Stem Cell Market Size (2013-2018)
  • 8.2. Cancer Stem Cell Key Players in Japan
  • 8.3. Japan Cancer Stem Cell Market Size by Type
  • 8.4. Japan Cancer Stem Cell Market Size by Application

9. Southeast Asia

  • 9.1. Southeast Asia Cancer Stem Cell Market Size (2013-2018)
  • 9.2. Cancer Stem Cell Key Players in Southeast Asia
  • 9.3. Southeast Asia Cancer Stem Cell Market Size by Type
  • 9.4. Southeast Asia Cancer Stem Cell Market Size by Application

10. India

  • 10.1. India Cancer Stem Cell Market Size (2013-2018)
  • 10.2. Cancer Stem Cell Key Players in India
  • 10.3. India Cancer Stem Cell Market Size by Type
  • 10.4. India Cancer Stem Cell Market Size by Application

11. Central & South America

  • 11.1. Central & South America Cancer Stem Cell Market Size (2013-2018)
  • 11.2. Cancer Stem Cell Key Players in Central & South America
  • 11.3. Central & South America Cancer Stem Cell Market Size by Type
  • 11.4. Central & South America Cancer Stem Cell Market Size by Application

12. International Players Profiles

  • 12.1. Thermo Fisher Scientific, Inc.
    • 12.1.1. Thermo Fisher Scientific, Inc. Company Details
    • 12.1.2. Company Description and Business Overview
    • 12.1.3. Cancer Stem Cell Introduction
    • 12.1.4. Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.1.5. Thermo Fisher Scientific, Inc. Recent Development
  • 12.2. AbbVie, Inc.
    • 12.2.1. AbbVie, Inc. Company Details
    • 12.2.2. Company Description and Business Overview
    • 12.2.3. Cancer Stem Cell Introduction
    • 12.2.4. AbbVie, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.2.5. AbbVie, Inc. Recent Development
  • 12.3. Merck KGaA
    • 12.3.1. Merck KGaA Company Details
    • 12.3.2. Company Description and Business Overview
    • 12.3.3. Cancer Stem Cell Introduction
    • 12.3.4. Merck KGaA Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.3.5. Merck KGaA Recent Development
  • 12.4. Bionomics
    • 12.4.1. Bionomics Company Details
    • 12.4.2. Company Description and Business Overview
    • 12.4.3. Cancer Stem Cell Introduction
    • 12.4.4. Bionomics Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.4.5. Bionomics Recent Development
  • 12.5. Lonza
    • 12.5.1. Lonza Company Details
    • 12.5.2. Company Description and Business Overview
    • 12.5.3. Cancer Stem Cell Introduction
    • 12.5.4. Lonza Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.5.5. Lonza Recent Development
  • 12.6. Stemline Therapeutics, Inc.
    • 12.6.1. Stemline Therapeutics, Inc. Company Details
    • 12.6.2. Company Description and Business Overview
    • 12.6.3. Cancer Stem Cell Introduction
    • 12.6.4. Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.6.5. Stemline Therapeutics, Inc. Recent Development
  • 12.7. Miltenyi Biotec
    • 12.7.1. Miltenyi Biotec Company Details
    • 12.7.2. Company Description and Business Overview
    • 12.7.3. Cancer Stem Cell Introduction
    • 12.7.4. Miltenyi Biotec Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.7.5. Miltenyi Biotec Recent Development
  • 12.8. PromoCell GmbH
    • 12.8.1. PromoCell GmbH Company Details
    • 12.8.2. Company Description and Business Overview
    • 12.8.3. Cancer Stem Cell Introduction
    • 12.8.4. PromoCell GmbH Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.8.5. PromoCell GmbH Recent Development
  • 12.9. MacroGenics, Inc.
    • 12.9.1. MacroGenics, Inc. Company Details
    • 12.9.2. Company Description and Business Overview
    • 12.9.3. Cancer Stem Cell Introduction
    • 12.9.4. MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.9.5. MacroGenics, Inc. Recent Development
  • 12.10. OncoMed Pharmaceuticals, Inc.
    • 12.10.1. OncoMed Pharmaceuticals, Inc. Company Details
    • 12.10.2. Company Description and Business Overview
    • 12.10.3. Cancer Stem Cell Introduction
    • 12.10.4. OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2013-2018)
    • 12.10.5. OncoMed Pharmaceuticals, Inc. Recent Development
  • 12.11. Irvine Scientific
  • 12.12. STEMCELL Technologies Inc.
  • 12.13. Sino Biological Inc.
  • 12.14. BIOTIME, Inc.

13. Market Forecast 2018-2025

  • 13.1. Market Size Forecast by Regions
  • 13.2. United States
  • 13.3. Europe
  • 13.4. China
  • 13.5. Japan
  • 13.6. Southeast Asia
  • 13.7. India
  • 13.8. Central & South America
  • 13.9. Market Size Forecast by Product (2018-2025)
  • 13.10. Market Size Forecast by Application (2018-2025)

14. Analyst's Viewpoints/Conclusions

15. Appendix

  • 15.1. Research Methodology
    • 15.1.1. Methodology/Research Approach
      • 15.1.1.1. Research Programs/Design
      • 15.1.1.2. Market Size Estimation
      • 12.1.1.3. Market Breakdown and Data Triangulation
    • 15.1.2. Data Source
      • 15.1.2.1. Secondary Sources
      • 15.1.2.2. Primary Sources
  • 15.2. Disclaimer
  • 15.3. Author Details
Back to Top